glp-1 news nov 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1s: The Swiss Army Knife

At Lite Medical, we approach obesity as a metabolic condition, not a character flaw

Wegovy and Saxenda coverage depends on whether your plan includes weight management benefits

NAD+ supports the mitochondrial machinery that converts available fuel into usable energy

And a few, particularly those related to Akkermansia muciniphila , raise legitimate safety questions that deserve serious attention, especially for people with autoimmune conditions, compromised immune systems, or inflammatory bowel disease

Opportunities for Retail With the shift in consumer behaviors due to GLP-1 drugs, there has been a significant impact on purchasing patterns, thus influencing retailers

How Long Do GLP-1 Side Effects Last